AI-assisted, human-published
09/06/2024 /Funding Events
OrsoBio, Inc. Secures $67M Funding to Accelerate Obesity Treatment Development
OrsoBio, Inc. has successfully closed a $67M Series B financing round to expedite the development of its obesity treatment portfolio, with a focus on mitochondrial protonophores and potential therapies for associated disorders.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com